3251 - 3260 of 7939 Results
Title
Year
- Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit2021OPENTitle: Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter AuditJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 541End Page: 545Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13181Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13181Citation Count: 5
-
OPENTitle: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2086Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2086Citation Count: 5
-
OPENTitle: Physical activity as a mediator of anxiety and cognitive functioning in Parkinson's diseaseJournal Name: Mental Health and Physical ActivityPublisher: Elsevier BVVol: 20Issue #:Start Page: 100382End Page: 100382Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.mhpa.2021.100382Best OA location URL: https://doi.org/10.1016/j.mhpa.2021.100382Citation Count: 3
-
OPENTitle: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 788End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28500Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/167074/1/mds28500_am.pdfCitation Count: 1
-
RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
-
RESTRICTEDTitle: The role of immune-mediated alterations and disorders in ALS diseaseJournal Name: Human ImmunologyPublisher: Elsevier BVVol: 82Issue #: 3Start Page: 155End Page: 161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.humimm.2021.01.017Best OA location URL: https://doi.org/10.1016/j.humimm.2021.01.017Citation Count: 19
-
OPENTitle: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00162-1Best OA location URL: https://www.nature.com/articles/s41531-021-00162-1.pdfCitation Count: 13
-
OPENTitle: TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respirationJournal Name: Cell ReportsPublisher: Elsevier BVVol: 34Issue #: 12Start Page: 108895End Page: 108895Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.108895Best OA location URL: http://www.cell.com/article/S2211124721002096/pdfCitation Count: 42
-
RESTRICTEDTitle: Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 155End Page: 163Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.005Best OA location URL: http://www.prd-journal.com/article/S1353802021000201/pdfCitation Count: 4
-
OPENTitle: Will the COVID-19 Pandemic Finally Fuel Drug Repurposing Efforts?Journal Name: American Journal of Medical QualityPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 36Issue #: 2Start Page: 122End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/01.jmq.0000735440.58551.5bBest OA location URL: https://europepmc.org/articles/pmc8030874?pdf=renderCitation Count: 0